Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-055697
Filing Date
2021-04-27
Accepted
2021-04-27 17:16:27
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F tm2113462d1_20f.htm 20-F 1426178
2 EXHIBIT 2.4 tm2113462d1_ex2-4.htm EX-2.4 147362
3 EXHIBIT 8.1 tm2113462d1_ex8-1.htm EX-8.1 3471
4 EXHIBIT 12.1 tm2113462d1_ex12-1.htm EX-12.1 8024
5 EXHIBIT 12.2 tm2113462d1_ex12-2.htm EX-12.2 7997
6 EXHIBIT 13.1 tm2113462d1_ex13-1.htm EX-13.1 4283
7 EXHIBIT 13.2 tm2113462d1_ex13-2.htm EX-13.2 4272
8 EXHIBIT 15.1 tm2113462d1_ex15-1.htm EX-15.1 2077
9 GRAPHIC tm2113462d1_20fimg001.jpg GRAPHIC 40382
10 GRAPHIC tm2113462d1_img001.jpg GRAPHIC 41045
11 GRAPHIC tm2113462d1_img002.jpg GRAPHIC 16129
12 GRAPHIC tm2113462d1_img003.jpg GRAPHIC 6088
13 GRAPHIC tm2113462d1_img004.jpg GRAPHIC 9370
14 GRAPHIC tm2113462d1_img005.jpg GRAPHIC 12245
15 GRAPHIC tm2113462d1_img006.jpg GRAPHIC 29203
16 GRAPHIC tm2113462d1_img007.jpg GRAPHIC 14519
  Complete submission text file 0001104659-21-055697.txt   1838565
Mailing Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)

EIN.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39308 | Film No.: 21860066
SIC: 2834 Pharmaceutical Preparations